Financials
- Market Capitalization 14.02 B
- Employee 1 077
- Founded 1994
- CEO Michael M. Morrissey
- Website www.exelixis.com
- Headquarter Delaware, United States
- FIGI BBG000BQ4WF8
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
15.68
Relación precio/flujo de caja
5.29
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 662 | ASND Ascendis Pharma A/S - American Depositary Shares | 265.57 USD | +0.13% | -0.77% | +18.83% | +29.50% | 16.46 B USD | ||
| 708 | JAZZ Jazz Pharmaceuticals plc - Ordinary Shares | 238.05 USD | +0.46% | -3.84% | +3.11% | +70.04% | 14.94 B USD | ||
| 802 | MDGL Madrigal Pharmaceuticals, Inc. - Common Stock | 536.86 USD | +1.10% | -1.03% | +6.29% | +26.73% | 12.38 B USD | ||
| 816 | AXSM Axsome Therapeutics, Inc. - Common Stock | 235.26 USD | +3.06% | -5.65% | -7.75% | +80.69% | 12.11 B USD |